ClinicalTrials.Veeva

Menu
A

Azienda Sanitaria Universitaria Friuli Centrale | Rheumatology Department

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Encorafenib
Binimetinib
5-Fluorouracil
Capecitabine
THR-149
Panitumumab
Hydroxyurea
Solu-Medrol
Trifluridine
Trastuzumab

Parent organization

This site is a part of Azienda Sanitaria Universitaria Friuli Centrale

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

7 of 24 total trials

A Clinical Trial of Three Study Medicines (Encorafenib, Binimetinib, and Pembrolizumab) in Patients With Advanced or Metastatic Melanoma

The purpose of this study is to learn about the effects of three study medicines (encorafenib, binimetinib, and pembrolizumab) given together for the...

Active, not recruiting
Melanoma
Drug: Binimetinib
Drug: Encorafenib
Locations recently updated

This study is researching an experimental drug called odronextamab, referred to as study drug, when used in combination with chemotherapy. The study...

Active, not recruiting
Diffuse Large B-cell Lymphoma (DLBCL)
Drug: Cyclophosphamide
Drug: Odronextamab

The purpose of the Columbus-AD study is to evaluate the efficacy and safety of 12 months of encorafenib in combination with binimetinib in adjuvant s...

Active, not recruiting
Melanoma
Drug: Placebo to match Encorafenib ; Placebo to match Binimetinib
Drug: Encorafenib and Binimetinib

Phase 3, randomized, multicentre study to evaluate the efficacy and safety of dostarlimab versus carboplatin-paclitaxel in patients with MMR deficien...

Active, not recruiting
Endometrial Cancer
Drug: Carboplatin-Paclitaxel
Drug: Dostarlimab

This is a multicenter, randomized, open-label, Phase 3 study in participants with newly diagnosed multiple myeloma to evaluate the benefits of teclis...

Enrolling
Multiple Myeloma
Drug: Lenalidomide
Drug: Teclistamab

The goal of this study is to learn if tilpisertib fosmecarbil (formerly known as GS-5290) is effective and safe in treating participants with moderat...

Enrolling
Ulcerative Colitis
Drug: Tilpisertib Fosmecarbil
Drug: Placebo

The goal of this clinical trial is to compare the efficacy and safety of givinostat to hydroxyurea in Jak2V617F-positive high risk polycythemia vera...

Enrolling
Polycythemia Vera
Drug: Givinostat
Drug: Hydroxyurea

Trial sponsors

I
G
U
Angelini Pharma logo
A
C
Gilead Sciences logo
Ipsen logo
Italfarmaco logo
Oxurion logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems